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Phylogenetic analysis of the influenza hemagglutinin gene 
(HA) has suggested that commercial pigs in Chile harbor 
unique human seasonal H1-like influenza viruses, but fur-
ther information, including characterization of these viruses, 
was unavailable. We isolated influenza virus (H1N2) from 
a swine in a backyard production farm in Central Chile and 
demonstrated that the HA gene was identical to that in a 
previous report. Its HA and neuraminidase genes were most 
similar to human H1 and N2 viruses from the early 1990s 
and internal segments were similar to influenza A(H1N1)
pdm09 virus. The virus replicated efficiently in vitro and in 
vivo and transmitted in ferrets by respiratory droplet. Anti-
genically, it was distinct from other swine viruses. Hemag-
glutination inhibition analysis suggested that antibody titers 
to the swine Chilean H1N2 virus were decreased in persons 
born after 1990. Further studies are needed to characterize 
the potential risk to humans, as well as the ecology of influ-
enza in swine in South America.
In the past decade, variant swine-origin influenza A vi-ruses (swIAVs) of subtypes H1N2 and H3N2 have been 
associated with human infections, particularly in persons 
with close contact to swine (1–7), although evidence of 
human-to-human transmission is minimal. The emergence 
and subsequent pandemic caused by the unique influenza 
A(H1N1)pdm09 virus (pH1N1) from swine in 2009 high-
lights the public health threat posed by swIAVs, especial-
ly in populations having little preexisting immunity (8). 
Therefore, it is imperative to understand the circulation of 
swIAVs on a global level.
While our knowledge of the global diversity and evo-
lution of swIAVs has increased, less information has been 
available regarding swIAVs circulating in South America. 
Recently, subtypes H1N1, H1N2, and H3N2 were identified 
in commercial pigs in Chile (9). Phylogenetic analysis from 
18 swIAVs sequenced from a 2012 cross-sectional sampling 
of 22 production companies in Chile (95% of their commer-
cial swine) demonstrated extensive genetic diversity in the 
hemagglutinin (HA) segment (9). The human seasonal H1-
like viruses were unique to swine in Chile and not closely 
related to other H1 swIAVs. These viruses represented 2 
independent introductions from humans, with Chile H1 hu-
man I clade most closely related to human viruses from the 
late 1980s and Chile H1 human II clade most closely related 
to human viruses from the early 1990s (9). No further phylo-
genetic or virus characterization information was available.
In addition to commercial pig farming, Chile has an 
extensive backyard production system, a common form of 
animal production throughout the world. Backyard produc-
tion farms (BPFs) are a particular public health concern 
given poor biosecurity and close interaction between hu-
mans and multiple animal species (10). During 2014, we 
conducted active backyard production system surveillance 
in Chile’s main swine production area (11) and isolated a 
subtype H1N2 swIAV virus (A/swine/Chile/YA026/2014; 
sw/Chile). We performed phylogenetic analyses and full 
genomic sequencing on this virus to determine its relation-
ship with other known influenza isolates. We propagated 
it in primary human bronchial and swine respiratory epi-
thelial cells, as well as C57Bl/6 mice, to determine its in-
fectiousness. We also characterized its transmission using 
ferrets. Hemagglutination inhibition (HI) assays with hu-
man serum samples were done to assess the risk this virus 
poses for human infection, and serological analyses were 
conducted with pig serum samples from Chile to determine 
the prevalence of the virus and its risk for emergence. 
Materials and Methods
Study Area and Nasal Swab Sampling
Active surveillance was conducted as described (11) in 40 
BPFs in Central Chile, representing 90% of the backyard 
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production system. During this time, only 3 farms had 
swine (n = 3) available for sampling. We collected nasal 
samples using disposable sterile swabs, which were placed 
in 1 mL universal transport media. None of the animals 
were symptomatic.
H1N2 Virus Isolation
We screened nasal swab samples by real-time reverse 
transcription PCR for matrix gene as described (12). 
PCR-positive samples were centrifuged at 8,000 rpm 
for 15 min and the clarified supernatant (200 µL) inocu-
lated on MDCK cells in 24-well plates in duplicate and 
incubated at 37°C in 5% CO2 for 1 h. Following incu-
bation, cells were washed then incubated with Eagle’s 
minimum essential medium (MEM; MediaTech, Manas-
sas, VA, USA) supplemented with 2 mM glutamine, 
bovine serum albumin, and 1 µg/mL TPCK (L-1-tosyl-
amide-2-phenylethyl chloromethyl ketone)–trypsin un-
til cytopathic effect was observed. Then, cell superna-
tant was collected, centrifuged, and stored at −80°C as 
described (12). Only 1 virus was isolated: A/swine/
Chile/YA026/2014 (H1N2) (sw/Chile).
Cells
MDCK cells were cultured in MEM supplemented with 
2 mM glutamine and 10% fetal bovine serum (Gemini 
BioProducts, West Sacramento, CA, USA) and grown at 
37°C in 5% CO2. A549 cells were cultured in Dulbecco’s 
minimum essential medium (DMEM; Lonza, Walkersville, 
MD, USA) supplemented with 4.5 g/L glutamine and 10% 
fetal bovine serum and grown at 37°C in 5% CO2. Well- 
differentiated (transepithelial resistance >300 Ω × cm2), 
primary normal human bronchial epithelial (NHBE) cells 
were grown as previously described (13). In brief, cells 
were plated on collagen-coated membranes in bronchial 
epithelial basal media (Lonza) supplemented with Single-
Quots additives (Lonza) and media changed every 48 h. 
When cells became 100% confluent, basal media was re-
placed with DMEM:F12 (Lonza) supplemented with Sin-
gleQuots, and apical media was removed. Every 48–72 h, 
242 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 2, February 2017
Figure 1. Phylogenetic trees showing comparison of swine influenza virus (H1N2) from Chile (red) and reference viruses. We performed 
phylogenetic analyses on complete hemagglutinin (A) and neuraminidase (B) genome sequences using RAxML with 200-bootstrap 
replicates (21). Blue indicates control H1 viruses. Scale bars indicate number of substitutions per site.
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the apical surface was washed with 0.9% sodium chloride 
solution (Sigma, St. Louis, MO, USA). Cells were incu-
bated at the air-liquid interface at 37°C in 5% CO2. Primary 
swine nasal epithelial cells (sNECs) were prepared as de-
scribed (14). In brief, nasal swab specimens were collect-
ed, placed in 50 mL conical tubes, and incubated in phos-
phate-buffered saline (PBS) at 4°C for 10–15 min before 
centrifuging for 10 min at 300 × g at 4°C. The pellet was 
resuspended in supplemented DMEM:F12 and incubated 
on collagen-coated plates at 37°C in 5% CO2. Cells were 
plated onto transwells and, when 100% confluent, moved 
to an air–liquid interface to differentiate for 1–3 wk. sNECs 
were moved to 33°C 1 d before infection.
Virus Sequencing
Sanger sequencing of viral stocks was performed by the St. 
Jude Hartwell Center (12), and deep amplicon sequencing 
and assembly were conducted as described previously (15). 
Sequences can be obtained in GenBank (accession nos. 
CY207245–CY207252).
Viral Propagation
A/swine/Chile/YA026/2014 (H1N2, sw/Chile), A/Mem-
phis/3/1987 (H1N1, Mem/87), A/swine/Iowa/13-1015/2010 
(H1N2, sw/IA), A/swine/Indiana/26-0818/2011 (H1N2, 
sw/IN), A/swine/North Carolina/18161/2002 (H1N1, 
sw/NC), A/swine/Italy/1310-2/1995 (H1N1, sw/IT), and 
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Figure 2. Phylogenetic trees 
comparing the internal genes 
of swine influenza virus (H1N2) 
from Chile (red) and reference 
viruses. We performed 
phylogenetic analysis for the 
matrix (A), nucleoprotein (B), 
nonstructural (C), polymerase 
acid (D), polymerase basic 
(PB) 1 (E), and PB2 (F) gene 
segments by using RAxML with 
200-bootstraps replicates (21). 
Purple indicates location of 
control influenza A(H1N1)pdm09 
CA/09 virus. Scale bars indicate 
number of substitutions per site. 
Detailed phylogenetic trees 
for these genes are provided 
in online Technical Appendix 
Figures 1–6 (https://wwwnc.cdc.
gov/EID/article/23/2/16-1374-
Techapp1.pdf).
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A/California/04/2009 (pH1N1, CA/09) viruses were propa-
gated in the allantoic cavity of 10-day-old, pathogen-free, 
embryonic chicken eggs at 37°C and viral titers determined 
by 50% tissue culture infectious dose (TCID50) analysis as 
previously described (16,17). These viruses were used as 
comparators for all studies except the ferret experiments.
Phylogenetic Analysis
We performed sequence assembly and editing by using 
BioEdit version 7.2.5 (18) and sequence alignment with 
MUSCLE version 3.8.3 (19). Reference sequences were 
obtained from the Influenza Virus Resource at NCBI (20). 
Phylogenic relationships for each gene was inferred by 
maximum likelihood, incorporating a general time-revers-
ible model of nucleotide substitution with a gamma-distrib-
uted rate variation among sites by using RAxML version 
8.0 (21). A bootstrap resampling process of 200 repli-
cates was implemented to provide statistical robustness to 
each node.
Swine and Human Serum Samples
During 2013–2015, swine serum samples (n = 266, 1–24 
animals/BP) were collected from 80 BPFs in Central Chile, 
including the Valparaiso, Metropolitan, and Libertador 
General Bernardo O’Higgins regions. During 2009–2015, 
human serum samples were collected as part of an ongoing 
prospective observational study at the University of North 
Carolina Family Medicine Center (Chapel Hill, NC, USA). 
We chose a subset of these samples, collected 28–32 d af-
ter seasonal influenza vaccination; grouped them accord-
ing to birth decade (1920–1929, 1930–1939, 1940–1949, 
1950–1959, 1960–1969, 1970–1979, 1980–1989, and 
1990–1999; n = 7–22/age group); and balanced for sex and 
race whenever possible (22).
Hemagglutination Inhibition Assay
Ferret antiserum was generated against sw/Chile, Mem/87, 
sw/IA, CA/09, sw/IN, sw/NC, and sw/IT viruses. HI assay 
was conducted as previously described (23). In brief, anti-
serum was treated with receptor-destroying enzyme (Den-
ka Seiken, Tokyo, Japan), inactivated, and diluted 1:10. Se-
rial dilutions of receptor-destroying enzyme–treated serum 
were incubated in duplicate with each virus for 15 min at 
room temperature, followed by 30 min incubation at 4°C 
with 0.5% turkey erythrocytes. HI titer was defined as the 
reciprocal dilution of the last well that reacted.
In Vitro Replication
MDCK cells were infected with a multiplicity of infection 
(MOI) of 0.01 for 1 h at 37°C. Cells were washed 3 times to 
remove unbound virus, and infected cells were cultured in 
MEM containing 0.075% bovine serum albumin and 1 μg/
mL TPCK-treated trypsin. Aliquots of culture supernatants 
were collected at 6 h postinfection (hpi), 24 hpi, 48 hpi, 
and 72 hpi and immediately stored at −80°C. For infection 
of NHBE cells and sNECs, the apical surface was washed 
twice and incubated with serum-free DMEM containing vi-
rus for 2 h at 37°C, after which both apical and basal media 
were removed and fresh growth medium was added to the 
basal chamber as described (24). At 6 hpi, 24 hpi, 48 hpi, 
72 hpi, and 96 hpi, DMEM was added to the apical surface, 
and cells were incubated for 30 min at 37°C (for NHBE) or 
33°C (for sNEC). Apical media was collected and stored at 
−80°C. Viral titers were determined by TCID50 on MDCK 
cells followed by Reed-Munch analysis (25).
Animal Infections
Six- to 8-week-old female BALB/c mice (Jackson Labo-
ratory, Bar Harbor, ME, USA) (n = 11 mice/group) were 
lightly anesthetized with isofluorane and intranasally in-
oculated with PBS or 105 TCID50 units of virus in 25 μL 
PBS. Mice were monitored daily for signs of infection and 
weighed every 48 hpi (26). At 3 d postinfection (dpi) and 
6 dpi, 3 control and 3 infected mice were humanely killed; 
lungs were harvested and homogenized in 1 mL PBS and 
nasal washes were collected as previously described (27). 
In brief, an incision was made in the trachea and 500 µL 
of PBS was flushed through the upper respiratory tract and 
collected. Viral titers were determined by TCID50 (16,24). 
Data are representative of 2 separate experiments. For 
transmission studies, 9- to 15-week-old male ferrets (n = 
2, Triple F Farms, Sayre, PA, USA) were intranasally in-
oculated with 106 TCID50 units in 1 mL PBS. Twenty-four 
hours later, naive ferrets (n = 2 mice/group) were either 
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Table. Antigenic characteristics of swine influenza virus (H1N2) from Chile and control viruses* 
Virus Subtype Major clade Subclade 
Ferret antiserum results 
Mem/87 sw/Chile sw/IA sw/NC sw/IT CA/09 
Mem/87 hsH1N1 North America δ 640 < < < < < 
sw/Chile swH1N2 North America δ < 640 < < < < 
sw/Iowa swH1N2 North America δ1 < < 320 < < < 
sw/NC swH1N1 North America γ2 < < < 80 < 80 
sw/It swH1N1 Eurasian - < < < < 320 40 
CA/09 pH1N1 North America pdm-like < < < < < 320 
sw/In swH1N2 North America β < < < 320 160 40 
*< refers to titers being below the minimum detectable hemagglutinin inhibition titer of 1:10. CA/09, A/California/04/2009; hs, human seasonal; MEM/87, 
A/Memphis/3/1987; pdm, pandemic; pH1N1, influenza A(H1N1)pdm09 virus; sw, swine; sw/Chile, A/swine/Chile/YA026/2014; sw/IA, A/swine/Iowa/13-
1015/2010; sw/IN, A/swine/Indiana/26-0818/2011; sw/IT, A/swine/Italy/1310-2/1995; sw/NC, A/swine/North Carolina/18161/2002. 
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placed in direct contact with infected ferrets or housed in 
separate cages (respiratory contact) separated by ≈5 inches. 
Nasal washes were collected every 2 dpi for viral titra-
tion and serum samples collected at 21 dpi for HI analysis 
as described (28).
Ethics Statement
All sampling was approved by the ethics and biosecurity 
committee of Faculty of Veterinary Science, University 
of Chile, and collected by trained veterinarians accord-
ing to Food and Agriculture Organization guidelines 
(http://www.fao.org/3/a-ak738e.pdf). Animal experi-
ments were approved by the St. Jude Children’s Re-
search Hospital institutional biosafety committee and 
animal care and use committee and were in compliance 
with the Guide for the Care and Use of Laboratory Ani-
mals. These guidelines were established by the Institute 
of Laboratory Animal Resources and approved by the 
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Figure 3. Testing for influenza in 
swine from backyard production 
farms (BPFs) in Central Chile. 
Swine serum samples collected 
from BPFs were analyzed for 
antibodies against influenza 
by nucleoprotein (NP)–specific 
ELISA, and hemagglutination 
inhibition analysis of serum 
samples from NP ELISA–
positive farms was conducted to 
determine subtype. A) Results 
of influenza testing by BPF 
location. Red circles indicate 
location of positive farms, and 
gray circles indicate location of 
negative farms. B) Pie charts 
showing percentage of swine at 
each sampling site seropositive 
for each virus type: sw/Chile 
(red), CA/09 (yellow), sw/IA 
(green), and sw/NC (blue).  
Red star indicates location of sw/
Chile H1N2 virus isolate. Insets 
indicate region of Central Chile 
covered by this study  
(red shading).
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Governing Board of the US National Research Coun-
cil. All human procedures were approved by the Bio-
medical Institutional Review Board at the University of 
North Carolina.
Statistical Analysis
We performed statistical analyses using JMP statistical 
software (SAS Institute, Cary, NC, USA) and GraphPad 
Prism software (GraphPad Software Inc., La Jolla, CA, 
USA). The Kruskal-Wallis test (α = 0.05) was used to ana-
lyze nonparametric data, while normally distributed data 
were analyzed by 2-way analysis of variance with virus 
strain and time postinfection as main effects. The Student 
t-test was used for posthoc comparisons between the vi-
ruses, and Tukey’s honest significant difference was used 
for posthoc comparisons among the times postinfection. 
Differences were considered significant at p<0.05.
Results
Phylogenetic Similarity of Chilean H1N2 and Human 
Seasonal Viruses
Phylogenetic analysis demonstrated that sw/Chile H1N2 
belongs to the δ-like H1 subgroup (Figure 1, panel A) and 
is phylogenetically similar to the swIAVs from Chile de-
scribed by Nelson et al. (9). The HAs of these swIAVs are 
closely related to the HAs of human seasonal H1 viruses 
from the late 1980s and early 1990s (closest relative A/Sui-
ta/1/89, 94% nucleotide identity), although they are sepa-
rated by long branch lengths and represent over 15 years of 
evolution (9). Unfortunately, only the HA segments from 
the 2012 Chilean swIAVs were available in public data-
bases, so we were unable to compare full genomes. 
The sw/Chile neuraminidase (NA) segment arose from 
a reassortment between human seasonal H1N1 and H3N2 
viruses (Figure 1, panel B). However, long branch length 
indicates extensive genetic divergence from human N2 se-
quences, with the closest sequence being an early 1990s 
North American H3N2 virus (A/New York/762/1993, 93% 
nucleotide identity). This difference can be indicative of 
possible temporal and species-specific adaptations, lead-
ing to genetic and antigenic differences with contemporary 
human N2 viruses. The sw/Chile virus internal genes are 
pH1N1 in origin, consistent with the high reassortment 
rate between pH1N1 and swine viruses (Figure 2; online 
Technical Appendix Figures 1–6, https://wwwnc.cdc.gov/
EID/article/23/2/16-1374-Techapp1.pdf) (9,29). Overall, 
while sw/Chile does appear to originally be of human ori-
gin, detection of these viruses in multiple BPFs suggests 
these viruses might have become established in the swine 
population in Chile.
Antigenicity and Seroprevalence of Chilean  
H1N2 Virus
HI assays with a panel of ferret antiserum against classi-
cal swIAV (sw/IN and sw/NC from β and γ subgroups, 
respectively); pandemic CA/09 virus; sw/Iowa (from δ 
subgroup); and human seasonal H1 virus Mem/87 showed 
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Figure 4. Replication of influenza viruses in vitro. MDCK cells 
(A), primary normal human bronchial epithelial cells (B), or 
primary swine nasal epithelial cells (C) were grown in an air-liquid 
interface and infected with the indicated viruses at a multiplicity 
of infection of 0.01. Cell culture supernatants were collected at 
6 hours postinfection (hpi), 24 hpi, 48 hpi, and 72 hpi, for MDCK 
cells and 6 hpi, 24 hpi, 48 hpi, 72 hpi, and 96 hpi for primary 
normal human bronchial epithelial cells and primary swine nasal 
epithelial cells, and viral titers were determined by 50% tissue 
culture infectious dose (TCID50) analysis. Data are presented as 
mean titer of 3 replicates ± SEM. *p<0.05 versus sw/Chile virus. 
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that sw/Chile H1N2 virus was antigenically distinct from 
other H1 viruses (Table). To determine seroprevalence in 
swine within the surveillance area, serum samples (n = 
266, 1–24 animals/BPF) were collected from swine on 80 
BPFs in Central Chile in 2013–2015. Forty-eight (60%) 
BPFs were positive by nucleoprotein-specific ELISA, and 
the prevalence of positive pigs (86/266, 32.3%) on each 
BPF ranged from 14.2% to 100% animals (Figure 3, panel 
A). HI assays performed with a panel of influenza viruses 
on the ELISA-positive samples demonstrated that 14/48 
(29.1%) BPFs and 22/86 pigs were positive for >1 of the 
test viruses. Antibodies against sw/Chile were identified in 
BPFs located in 3 regions of Central Chile (Figure 3, panel 
B). Of concern, 11/14 (78.6%) of the positive BPFs, repre-
senting 15/22 (68.2%) of the positive samples, were posi-
tive for multiple influenza strains, suggesting that different 
influenza viruses are co-circulating in backyard swine in 
Central Chile (Figure 3, panel B). Not all nucleoprotein 
ELISA–positive samples could be subtyped.
Chile H1N2 Virus in Primary Swine and Human Cells 
Swine possess both mammalian (α-2,6) and avian (α-2,3) 
influenza receptors (30,31). Receptor binding assays (23) re-
vealed that all viruses used in this study had greater binding 
affinity for mammalian-type (α-2,6–linked sialic acid) recep-
tors (online Technical Appendix Figure 7). These viruses also 
replicated effectively in MDCK cells; differentiated, primary 
NHBE cells; and sNECs cultured at the air-liquid interface. 
Cells were infected at MOI 0.01 and viral titers determined at 
the indicated times by TCID50 analysis on MDCK cells (23). 
All viruses replicated to similar titers in MDCK cells (Figure 
4, panel A) and sNECs (Figure 4, panel C), except for an 
increased replication of CA/09 virus in MDCK cells. How-
ever, significant differences in replication were observed in 
primary NHBE cells. The human seasonal Mem/87 and sw/
Chile viruses replicated to lower titers than the other swine 
viruses, suggesting reduced fitness in human cells (Figure 4, 
panel B). Overall, these studies demonstrate that sw/Chile 
can productively replicate in human and swine cells.
Chile H1N2 Virus in Mice
Recently identified swine H1N2 viruses from China rep-
licated efficiently in mice and pigs (32); however, no data 
were available on viruses from South America. Thus, we 
intranasally inoculated Balb/c mice with 105 TCID50 units 
of each virus and monitored weight loss for 14 dpi. Viral 
titers were measured 3 dpi and 6 dpi (Figure 5). CA/09 vi-
rus caused considerable weight loss, as did sw/IA (H1N2, 
δ1 subclade), which was similar to CA/09, sw/IN (H1N2, 
β subclade), and sw/NC (H1N1, γ2 subclade) viruses. In-
creased weight loss was associated with efficient replica-
tion in lungs (Figure 5, panel B). In contrast, the Mem/87 
and sw/Chile viruses caused minimal illness and had lower 
replication in lungs (Figure 5, panels A and B). The sw/
Chile virus replicated the most effectively in the upper 
respiratory tract compared with the other swine viruses, 
which reached titers similar to that of CA/09 virus (Fig-
ure 5, panel C). These data show that while sw/Chile virus 
can replicate in mice, it causes minimal illness. The genetic 
basis for differences in pathogenicity and tropism between 
the swine strains warrants further investigation.
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Figure 5. Replication of influenza viruses in vivo. To evaluate 
pathogenicity in mice, 6- to 8-week-old BALB/c mice (n = 11 mice/
group/experiment) were infected with 105 50% tissue culture 
infectious dose (TCID50) units of the indicated viruses and weight 
loss was monitored for 14 days postinfection (dpi) (A). At 3 dpi and 
6 dpi, lungs (B) and nasal washes (C) were collected from 3 mice/
group and viral titers were determined by TCID50 analysis. Data 
are presented as mean ± SEM. *p<0.05 versus sw/Chile virus.
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Chile H1N2 Virus in Respiratory Droplets
Eurasian swine H1N2 viruses transmit in ferrets by direct 
contact and, in some cases, by respiratory droplet (33,34). 
To test the transmissibility of sw/Chile virus, we intra-
nasally inoculated ferrets with 106 TCID50 units of sw/
Chile, Mem/87, or sw/IA viruses; at 1 dpi, naive ferrets 
were either placed in direct contact or housed in cages 
adjacent to the donor ferrets to monitor respiratory droplet 
transmission. Nasal washes were collected every 2 dpi to 
assess viral shed, and animals were monitored through 21 
dpi. All of the donor animals shed virus, and all viruses 
transmitted through direct contact and respiratory drop-
let with some differences (Figure 6). Overall, the swine 
viruses replicated to a higher titer than the Mem/87 virus 
did in the donor and direct contact animals; swine viruses 
also transmitted faster by respiratory droplet. Respiratory 
contacts of sw/Chile virus–inoculated animals were shed-
ding virus by 6 dpi, whereas Mem/87 virus–inoculated 
animals only showed detectable nasal washes after 8 dpi 
and 10 dpi. The sw/IA virus appeared to transmit faster 
and replicate to higher titer than did the sw/Chile and 
Mem/87 viruses (Figure 6). All animals seroconverted at 
21 dpi. These studies highlight that both swine H1 δ vi-
ruses transmitted effectively in ferrets.
Decreased HI Antibody Titer in Persons Born  
after 1990 
Because the HA and NA of sw/Chile were derived from hu-
man seasonal strains originating around 1990, we hypoth-
esized that persons born after 1990 would have decreased 
HI antibody titers. To test this, we conducted HI analyses 
against CA/09, Mem/87, sw/IA, and sw/Chile viruses on 
serum samples from 137 persons in North America col-
lected in 2010–2015; samples were grouped by decade of 
birth (n = 7–22 samples/group). Most persons born before 
1990 had titers against all 4 viruses (Figure 7). However, 
few persons born after 1990 had titers against sw/Chile 
(9%; Figure 7, panel B); sw/IA (31.8%; Figure 7, panel 
C); or Mem/87 (27.2%; Figure 7, panel D) viruses. Per-
sons with titers ranging from 1:10 to 1:160 were all born in 
1990 or 1991. In contrast, most (91.7%) persons born after 
1990 had titers against pH1N1 virus, ranging from 1:320 to 
1:10,240 (Figure 7, panel A).
Discussion
Our data show that the swine H1N2 virus from Chile is 
antigenically distinct from other H1 viruses, replicates ef-
ficiently in mammalian cells, can transmit by respiratory 
droplet, and might pose a risk to immunologically naive 
persons born after 1990. Our study furthers the data re-
cently published on prevalence and HA phylogeny of Chile 
swIAVs (9). We show that these viruses are circulating out-
side of commercial swine herds in BPFs, where animal–hu-
man interaction is high.
Since emergence of pH1N1 in 2009, reverse transmis-
sion of the virus from humans to pigs has been documented 
worldwide, resulting in several reassortments with classical 
swine and seasonal human viruses (1,2,4,5,9,12,35). As of 
July 2016, variant (v) influenza viruses have caused over 
380 human infections in the United States alone. While 
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Figure 6. Evaluation of H1 virus transmission in ferrets. Donor 
ferrets (black lines; n = 2 ferrets/group) were inoculated with 106 
50% tissue culture infectious dose (TCID50) units of H1 influenza 
virus sw/Chile (A), Mem/87 (B), or sw/IA (C) viruses. Naive ferrets 
(n = 2) were either placed in the same cage with the infected 
group (direct contact, blue lines) or housed in separate cages 
(respiratory transmission, red lines) and nasal washes were 
collected on the indicated day postinfection for virus quantification 
by TCID50 analysis. Lines represent individual animals. Dashed 
line represents limit of detection of the assay.
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most of these infections have been H3N2v viruses, 8 have 
been H1N2v viruses. These infections are particularly con-
cerning because most infections occurred in children (per-
sons <18 years of age) who had direct or indirect exposure 
to swine (2). Census estimates indicate that 50% of BPFs 
in Chile have >1 person born after 1990, and 35% have >1 
person born after 2000 (C. Hamilton-West, unpub. data). 
Our data indicate that younger age groups have reduced 
HI titers to sw/Chile virus; however, studies with serum 
samples obtained from throughout the population of Chile 
are warranted to better determine the risk these viruses pose 
to swine herds.
This study is subject to several limitations. First, these 
studies were limited to 1 virus isolate. A panel of swine 
viruses from Chile isolated from different years and regions 
warrant study, especially if genetic differences are found 
among viruses. Second, these results represent a limited 
number of the backyard production system within Chile. 
Enhanced swine surveillance throughout Chile and South 
America is needed. Third, studies at the animal–human in-
terface are required to decipher the risk circulating swIAVs 
pose to humans. We were limited to serum samples from 
persons living in North America, and further work should 
be done on South America populations, especially with 
those exposed to swine. Antigenic cartography on serum 
samples from persons involved in backyard farming would 
provide invaluable new information on transmission of 
swine viruses to humans. Finally, further work is needed to 
improve understanding of swIAV genes involved in trans-
mission in the ferret model.
Despite no evidence of sustained human-to-human 
transmission, increased risk for human infection with 
H1N2v viruses calls for further study and enhanced moni-
toring. Risk for possible emergence of zoonotic strains 
has been demonstrated worldwide. H1N2 viruses isolated 
from pigs in China replicated efficiently in mice and pigs 
(32,36,37), while viruses from South Korea and Europe 
transmitted to and even caused death in ferrets (33,34,38). 
Future work will focus on how these reassortants arose in 
Chile BPFs and the role of specific genetic differences in 
pathogenicity and transmissibility. In addition, further stud-
ies for seroprevalence in Chile BPF workers and antigenic 
cartography with the sw/Chile virus are necessary. Stud-
ies at the animal–human interface are needed to determine 
seroprevalence, identify broadly protective antibodies, and 
characterize T-cell responses, and active surveillance is 
needed to uncover infection rates to better determine the 
risk for zoonotic transmission of swine-origin H1N2 to hu-
man health. In summary, our findings highlight the need 
for continued, vigilant influenza virus surveillance in Chile 
and throughout South America.
Acknowledgments
We thank Nicola Lewis, Amy Vincent, and Richard Webby 
for critical discussions and reagents; Dr. Webby for providing 
CA/09, sw/IN, sw/NC, and sw/IT antisera; Scott Krauss,  
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 2, February 2017 249
Figure 7. Evaluation of 
serologic responses of 
humans to H1 viruses by 
age. Hemagglutination 
inhibition (HI) studies were 
performed for CA/09 (A), 
sw/Chile (B), sw/IA (C), 
and Mem/87 (D) viruses by 
using human serum samples 
(n = 137) collected as part 
of an ongoing prospective 
observational study carried 
out at the University of North 
Carolina Family Medicine 
Center (Chapel Hill, NC, USA) 
in 2009–2015. A subset of 
the available samples were 
chosen from persons whose 
serum samples were collected 
28–32 days after seasonal 
influenza vaccination. 
Samples were grouped by 
decade of birth (1920–1929, 
1930–1939, 1940–1949, 
1950–1959, 1960–1969, 
1970–1979, 1980–1989, 
and 1990–1999). Groups 
consisted of samples from 7–22 persons and were balanced for sex and age whenever possible. Gray dots represent inverse HI 
titers of individual persons and bars represent mean HI titer ± SEM per decade born.
RESEARCH
Sean Cherry, Cydney Johnson, and Bridgett Sharp for expert 
technical assistance; and Andrés Lazo for sample collection. 
This work was supported by the National Institutes of Health 
National Institute of Allergy and Infectious Diseases  
contract number HHSN272201400006C (to S.S.C. and C.H.W.), 
ALSAC and Fondecyt grant 11121389 (to S.S.C.), and Feline 
Influenza Virus 121014019102011 (to C.H.W.).
Dr. Bravo-Vasquez is a veterinarian and scientist in the  
Department of Preventive Veterinary Medicine at the University 
of Chile, Santiago, Chile. His primary research interests are 
virology and epidemiology of influenza viruses.
References
  1. Komadina N, McVernon J, Hall R, Leder K. A historical  
perspective of influenza A(H1N2) virus. Emerg Infect Dis. 
2014;20:6–12. http://dx.doi.org/10.3201/eid2001.121848
  2. Centers for Disease Control and Prevention. Reported infections 
with variant influenza viruses in the United States since 2005. 
2016 Sep 12 [cited 2016 Oct 10]. http://www.cdc.gov/flu/swineflu/
variant-cases-us.htm
  3. Herriman R. Swine flu, H1N2v virus infections reported in  
Wisconsin, Minnesota. 2016 Jul 1 [cited 2016 Oct 10].  
http://outbreaknewstoday.com/swine-flu-h1n2v-virus-infections-
reported-in-wisconsin-minnesota-22255/
  4. Centers for Disease Control and Prevention. Influenza A (H3N2) 
variant virus [cited 2016 Oct 6]. http://www.cdc.gov/flu/swineflu/
h3n2v-cases.htm 
  5. Centers for Disease Control and Prevention. H1N2 variant virus 
detected in Minnesota. 2012 Sep 7 [cited 2016 Oct 6].  
http://www.cdc.gov/flu/spotlights/h1n2v-cases-mn.htm
  6. Trombetta C, Piccirella S, Perini D, Kistner O, Montomoli E. 
Emerging influenza strains in the last two decades: a threat of a 
new pandemic? Vaccines (Basel). 2015;3:172–85.  
http://dx.doi.org/10.3390/vaccines3010172
  7. Choi MJ, Morin CA, Scheftel J, Vetter SM, Smith K, Lynfield R.; 
Variant Influenza Investigation Team. Variant influenza associated 
with live animal markets, Minnesota. Zoonoses Public Health. 
2015;62:326–30. http://dx.doi.org/10.1111/zph.12139
  8. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, 
et al.; Novel Swine-Origin Influenza A (H1N1) Virus  
Investigation Team. Emergence of a novel swine-origin influenza A 
(H1N1) virus in humans. N Engl J Med. 2009;360:2605–15.  
http://dx.doi.org/10.1056/NEJMoa0903810
  9. Nelson M, Culhane MR, Rovira A, Torremorell M, Guerrero P, 
Norambuena J. Novel human-like influenza A viruses circulate in 
swine in Mexico and Chile. PLoS Curr. 2015;7:7. 
10. Hamilton-West C, Rojas H, Pinto J, Orozco J, Hervé-Claude LP,  
Urcelay S. Characterization of backyard poultry production 
systems and disease risk in the central zone of Chile. Res Vet Sci. 
2012;93:121–4. http://dx.doi.org/10.1016/j.rvsc.2011.06.015
11. Bravo-Vasquez N, Di Pillo F, Lazo A, Jiménez-Bluhm P,  
Schultz-Cherry S, Hamilton-West C. Presence of influenza  
viruses in backyard poultry and swine in El Yali wetland, Chile.  
Prev Vet Med. 2016;134:211–5. http://dx.doi.org/10.1016/ 
j.prevetmed.2016.10.004
12. Karlsson EA, Ciuoderis K, Freiden PJ, Seufzer B, Jones JC,  
Johnson J, et al. Prevalence and characterization of influenza  
viruses in diverse species in Los Llanos, Colombia. Emerg  
Microbes Infect. 2013;2:e20. http://dx.doi.org/10.1038/emi.2013.20
13. Fulcher ML, Randell SH. Human nasal and tracheo-bronchial 
respiratory epithelial cell culture. In: Randell HS, Fulcher LM, 
editors. Epithelial cell culture protocols, 2nd ed. Totowa (NJ): 
Humana Press; 2013. p. 109–21.
14. Dash P, Barnett PV, Denyer MS, Jackson T, Stirling CMA,  
Hawes PC, et al. Foot-and-mouth disease virus replicates  
only transiently in well-differentiated porcine nasal  
epithelial cells. J Virol. 2010;84:9149–60. http://dx.doi.org/ 
10.1128/JVI.00642-10
15. Kaplan BS, Russier M, Jeevan T, Marathe B, Govorkova EA, 
Russell CJ, et al. Novel highly pathogenic avian A(H5N2) and 
A(H5N8) influenza viruses of clade 2.3.4.4 from North America 
have limited capacity for replication and transmission in mammals. 
mSphere. 2016;1:piie00003-16.
16. Jones JC, Turpin EA, Bultmann H, Brandt CR, Schultz-Cherry S. 
Inhibition of influenza virus infection by a novel antiviral peptide 
that targets viral attachment to cells. J Virol. 2006;80:11960–7. 
http://dx.doi.org/10.1128/JVI.01678-06
17. Carlson CM, Turpin EA, Moser LA, O’Brien KB, Cline TD,  
Jones JC, et al. Transforming growth factor-β: activation by  
neuraminidase and role in highly pathogenic H5N1  
influenza pathogenesis. PLoS Pathog. 2010;6:e1001136.  
http://dx.doi.org/10.1371/journal.ppat.1001136
18. Hall TA. BioEdit: a user-friendly biological sequence alignment 
editor and analysis program for Windows 95/98/NT. Nucleic Acids 
Symp Ser. 1999;41:95–8.
19. Edgar RC. MUSCLE: multiple sequence alignment with high  
accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. 
http://dx.doi.org/10.1093/nar/gkh340
20. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L,  
Tatusova T, et al. The influenza virus resource at the National 
Center for Biotechnology Information. J Virol. 2008;82:596–601. 
http://dx.doi.org/10.1128/JVI.02005-07
21. Stamatakis A. RAxML version 8: a tool for phylogenetic 
analysis and post-analysis of large phylogenies. Bioinformatics. 
2014;30:1312–3. http://dx.doi.org/10.1093/bioinformatics/btu033
22. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, 
Sammon AB, et al. Obesity is associated with impaired  
immune response to influenza vaccination in humans. Int J Obes. 
2012;36:1072–7. http://dx.doi.org/10.1038/ijo.2011.208
23. Karlsson EA, Ip HS, Hall JS, Yoon SW, Johnson J, Beck MA,  
et al. Respiratory transmission of an avian H3N8 influenza virus 
isolated from a harbour seal. Nat Commun. 2014;5:4791.  
http://dx.doi.org/10.1038/ncomms5791
24. Cline TD, Karlsson EA, Freiden P, Seufzer BJ, Rehg JE,  
Webby RJ, et al. Increased pathogenicity of a reassortant 2009  
pandemic H1N1 influenza virus containing an H5N1  
hemagglutinin. J Virol. 2011;85:12262–70. http://dx.doi.org/ 
10.1128/JVI.05582-11
25. Reed LJ, Muench H. A simple methods of estimating fifty percent 
endpoints. Am J Epidemiol. 1938;27:493–7.
26. Morton DB. A systematic approach for establishing humane 
endpoints. ILAR J. 2000;41:80–6. http://dx.doi.org/10.1093/
ilar.41.2.80
27. Zhou B, Meliopoulos VA, Wang W, Lin X, Stucker KM,  
Halpin RA, et al. Reversion of cold-adapted live attenuated  
influenza vaccine into a pathogenic virus. J Virol. 2016;90: 
8454–63. http://dx.doi.org/10.1128/JVI.00163-16
28.  Barman S, Krylov PS, Fabrizio TP, Franks J, Turner JC, Seiler P, 
et al. Pathogenicity and transmissibility of North American triple 
reassortant swine influenza A viruses in ferrets. PLoS Pathog. 
2012;8:e1002791. http://dx.doi.org/10.1371/journal.ppat.1002791
29. Nelson MI, Wentworth DE, Culhane MR, Vincent AL, Viboud C, 
LaPointe MP, et al. Introductions and evolution of human-origin 
seasonal influenza a viruses in multinational swine populations.  
J Virol. 2014;88:10110–9. http://dx.doi.org/10.1128/JVI.01080-14
30. Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM,  
Kiso M, et al. Sialic acid species as a determinant of the host  
250 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 2, February 2017
Swine Influenza Virus (H1N2), Chile
range of influenza A viruses. J Virol. 2000;74:11825–31.  
http://dx.doi.org/10.1128/JVI.74.24.11825-11831.2000
31. Ito T, Couceiro JNSS, Kelm S, Baum LG, Krauss S, Castrucci MR, 
|et al. Molecular basis for the generation in pigs of influenza A 
viruses with pandemic potential. J Virol. 1998;72:7367–73. 
32. Yang H, Chen Y, Qiao C, Xu C, Yan M, Xin X, et al. Two  
different genotypes of H1N2 swine influenza virus isolated in 
northern China and their pathogenicity in animals.  
Vet Microbiol. 2015;175:224–31. http://dx.doi.org/10.1016/ 
j.vetmic.2014.11.031
33. Lee JH, Pascua PNQ, Decano AG, Kim SM, Park S-J, Kwon H-I, 
et al. Evaluation of the zoonotic potential of a novel reassortant 
H1N2 swine influenza virus with gene constellation derived from 
multiple viral sources. Infect Genet Evol. 2015;34:378–93.  
http://dx.doi.org/10.1016/j.meegid.2015.06.005
34. Fobian K, Fabrizio TP, Yoon S-W, Hansen MS, Webby RJ,  
Larsen LE. New reassortant and enzootic European swine influenza 
viruses transmit efficiently through direct contact in the ferret 
model. J Gen Virol. 2015;96:1603–12. http://dx.doi.org/10.1099/
vir.0.000094
35. Nelson MI, Schaefer R, Gava D, Cantão ME, Ciacci-Zanella JR. 
Influenza A viruses of human origin in swine, Brazil. Emerg Infect 
Dis. 2015;21:1339–47. http://dx.doi.org/10.3201/eid2108.141891
36. Peng X, Wu H, Xu L, Peng X, Cheng L, Jin C, et al. Molecular 
characterization of a novel reassortant H1N2 influenza virus  
containing genes from the 2009 pandemic human H1N1 virus in 
swine from eastern China. Virus Genes. 2016;52:405–10.  
http://dx.doi.org/10.1007/s11262-016-1303-4
37. Liu H, Tao J, Zhang P, Yin X, Ha Z, Zhang C. Pathogenic  
characteristics of a novel triple-reasserted H1N2 swine influenza 
virus. Biologicals. 2016;44:252–6. http://dx.doi.org/10.1016/ 
j.biologicals.2016.05.002
38. Pascua PNQ, Song M-S, Lee JH, Baek YH, Kwon HI, Park S-J,  
et al. Virulence and transmissibility of H1N2 influenza virus in  
ferrets imply the continuing threat of triple-reassortant swine  
viruses. Proc Natl Acad Sci U S A. 2012;109:15900–5.  
http://dx.doi.org/10.1073/pnas.1205576109
Address for correspondence: Christopher Hamilton-West, Department 
of Preventive Veterinary Medicine, Faculty of Veterinary Sciences, 
University of Chile, Av Santa Rosa 11735, La Pintana, Santiago, Chile; 
email: christopher.hamilton@veterinaria.uchile.cl; Stacey Schultz-Cherry, 
St. Jude Children’s Research Hospital, 262 Danny Thomas Pl, MS 320, 
Memphis, TN 38105, USA; email: stacey.schultz-cherry@stjude.org
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 2, February 2017 251
• Turtle-Associated Salmonellosis, United States, 2006–2014  
•  Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in 
Obstetric Services, United States, 2015 
•  Response to Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 
2013–2014 
•  Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme 
Disease, United States
•  Two Linked Enteroinvasive Escherichia coli Outbreaks, Nottingham, United Kingdom, June 2014
•  Restaurant Cooking Trends and Increased Risk for Campylobacter Infection
• African Swine Fever Epidemic, Poland, 2014–2015
•  Comparing Disease Characteristics of Sporadic and Outbreak-
Associated Foodborne Illnesses, United States, 2004–2011 
• Heatwave-Associated Vibriosis, Sweden and Finland, 2014
• A Literature Review of Zika Virus 
•  High Incidence of Chikungunya Virus and Frequency  of Viremic 
Blood Donations during Epidemic, Puerto Rico, USA, 2014
•  Outbreak of Vibrio parahaemolyticus Sequence Type 120,  
Peru, 2009 
•  Clinical Manifestations of Senecavirus A Infection in Neonatal Pigs, 
Brazil, 2015 
• Infection with Possible Novel Parapoxvirus in Horse, Finland, 2013
• Natural Norovirus Infections in Rhesus Macaques 
http://wwwnc.cdc.gov/eid/articles/issue/22/7/table-of-contents
July 2016: Zoonoses 
